In confirmation of previous reports, we observed lysis of mouse hepatitis virus (MHV)-infected target ceils in the presence of spleen and lymph node cells from nonimmunized mice possessing a B cell surface phenotype (IgM +, IgG +, J1 ld +, Ia +, Fc +, Thyl-, MAC-l-and asialo-GM1-). Lysis was inhibited by MHV-specific antisera. The presence of immunoglobulin at the surface of B cells is not required for cytolysis since MHV-infected target cells are lysed in the presence of the B cell hybridoma Sp2/0, which fails to synthesize immunoglobulin. Using 51Cr-labeUed Sp2/0 cells, both target and effector cells were shown to undergo cytolysis. Direct observation of target and effector cells co-incubated after labelling with different fluorescent dyes demonstrated that lysis correlates with the fusion of B cells and MHV-infected cells. These findings are consistent with the idea that the E2 protein of MHV, which is expressed on the infected cell surface and has receptor and membrane-fusion activities at neutral pH, selectively mediates fusion with cells of B lymphocyte lineage. This may represent a general mechanism by which enveloped viruses with fusion proteins that function at neutral pH can interfere with the function of subsets of immune cells.
INTRODUCTION
Mouse hepatitis viruses (MHVs) are a closely related group of natural mouse pathogens that belong to the coronavirus family. The outcome of MHV infection in mice is influenced by the virus strain and the genetic background of the mouse. For example, MHV-3 causes lethal hepatitis in SJL mice, but A/J mice are fully resistant (Virelizier, 1981 ; Wege et al., 1982) . In contrast, MHV-4 is highly neurotropic and causes acute encephalomyelitis and demyelination of the central nervous system in A/J mice (Lampert et aL, 1973; Weiner, 1973) , while SJL mice are highly resistant (Knobler et al., 1981; Stohlman & Frelinger, 1978) . The well-characterized nature of both virus and host makes the MHV-mouse system ideal for studying questions of viral tropism, pathogenesis and the role of the immune system and genetic background in these processes.
As an initial step towards understanding the interaction of MHV with the immune system we have examined the cellular immune response to MHV. It has previously been reported that B cells from non-immune mice can mediate lysis of MHV-infected target cells Welsh et al., 1986) . In this study we show that target cell lysis does not require the expression of immunoglobulin by B cells, that lysis affects both target and effector cells; and that lysis represents virus-mediated fusion of effector and target cells.
antisera were produced by intraperitoneal immunization of mice with 106 p.f.u, of A59 virus.
RESULTS
Analysis of cytotoxicity in the presence of splenocytes derived directly from unprimed mice indicated that priming was not required to obtain lysis of MHV-infected target cells (Table 1) . Lysis of MHV-infected, but not uninfected target cells was observed in the presence of splenocytes from a number of non-immunized mouse strains. Non-immunized mice were routinely found to be negative for environmental exposure to MHV as determined by serological analysis for anti-MHV antibodies. Furthermore, immunization of mice with infectious MHV had no apparent effect on the MHV-infected target cell lysis.
Recognition of MHV-infected cells was clearly not major histocompatibility complex (MHC)-restricted, since L929 (H-2 k) and 17Cll (H-2 d) cells were lysed to an equal extent by splenocytes derived from H-2 d, H-2 b and H-2 k mice. Cytotoxicity also did not correlate with high levels of natural killer or natural cytotoxic cell activity since YAC (Table l) .
Target cells were infected by incubating cell monolayers with virus for 1.5 h at 37 °C followed by incubation for 16 h at 31 °C to delay cytopathic effects caused by the MHV(A59) virus (Koolen et al., 1983) .
Target cells were MHV-infected 17Cll and L929 ceils, and uninfected YAC cells. The effector :target cell ratios are shown. Evidence for the MHV-specific nature of cytolysis was obtained in antibody blocking experiments using target cells pretreated with anti-MHV or normal mouse sera. Extensive inhibition of lysis was observed using mouse anti-MHV serum but not normal mouse serum (Table 2) . Inhibition was specific since lysis of vaccinia virus-infected target cells by vaccinia virus-specific cytotoxic T lymphocytes was not altered by the anti-MHV serum (not shown).
To determine the phenotype necessary for cells to obtain MHV-infected target cell lysis, lymph node or spleen cells were treated with a number of antibodies specific for immune cell surface molecules in the presence of C'. Treatment with anti-asialo-GM1 (antinatural killer cell), anti-Thy 1.2 (anti-T cell), or anti-MAC-1 (anti-macrophage) antibodies plus C' had no effect on the cytotoxicity (Fig. 1) . In contrast, treatment with MAbs that bind to B cell surfaces [MK-D6 (anti-la d) and anti-Jlld (anti B cell)] inhibited lysis in the presence of BALB/c splenocytes by 50~o. Additional experiments using purified cell populations indicated that MHV-infected target cell lysis was observed in the presence of nylon wool-adherent, IgM ÷ or IgG ÷ cells (as determined by antibody panning using dishes coated with anti-IgM or anti-IgG sera) and IgG Fc ÷ cells [determined using IgG-coated sheep erythrocytes (SRBC)] (Fig. 2) . Variations in percentage lysis observed in different assays shown in Fig. 2 generally are thought to reflect differences in the extent of target cell infection. Overall, these findings are consistent with the idea that lysis of MHV-infected target cells occurs in the presence of cells of the B cell lineage.
To examine cytolysis of MHV-infected cells further, we used two different B cell tumour lines, A20 lymphoma and MOPC-21 plasmacytoma cells, and a number of their derivatives (Table 3) . MHV-infected target cells were lysed in the presence of A20 cells and a hybridoma produced by fusing A20 with B 10. S splenocytes. Curiously, although MHV-infected cells failed to be lysed in the presence of MOPC-21 and one of its derivatives (P3-X63-Ag8-653), it was lysed in the presence of another of its derivatives (P3-X63-Ag8), and hybridomas derived from this line by fusion with rat or mouse splenocytes. As expected, cytolysis of MHV-infected target cells was at an effector to target cell ratio of 30:1. Spontaneous release was 15~ and lysis of uninfected cells was less than 5~.
not observed with the thymoma BW5147. Importantly, lysis of MHV-infected target cells was observed with Sp2/0, (derived by fusion of P3-X63-Ag8 and BALB/c splenocytes) with anti-SRBC activity (Tables 3 and 4) . Although the level of lysis varied between experiments, the fact that Sp2/0 fails to synthesize immunoglobulin demonstrates that immunoglobulin is not required, nor responsible, for recognition or lysis of target cells. Additional experiments were performed to examine B cell recognition of MHV-infected cells using Sp2/0 cells. First, we confirmed that 51Cr release represents a true measure of target cell lysis by determining the viability of target cells using trypan blue (not shown). Secondly, lysis of MHV-infected L929 cells was not mediated by stable soluble factors since lytic activity could not be transferred via supernatants derived from wells containing Sp2/0 and unlabelled MHVinfected cells co-incubated for 4 h at 37 °C (not shown). Thirdly, lysis of virus-infected cells is accompanied by lysis of B cells, since when unlabelled L929 MHV-infected cells were coincubated with 51Cr_labelled Sp2/0 cells, specific S~Cr release was observed (Table 4) .
The last result suggested to us that MHV-infected cell lysis could be a result of a virus-induced fusion between effector and target cells. We examined this possibility via double fluorescent microscopy using cells whose membranes were labelled with R18 (MHV-infected L929 cells) and F18 (Sp2/0 cells). When Sp2/0 and MHV-infected L929 cells were co-incubated at 37 °C and observed under transmitted light illumination, clusters of Sp2/0 cells were frequently observed surrounding the larger MHV-infected L929 cells. Such clusters were not observed using noninfected L929 ceils. Polykaryons were frequently observed in the L929 Sp2/0 cell clusters (not shown). Observation under epifluorescent illumination revealed that in contrast to individual cells, polykaryons were stained with R18 and F18 (Fig. 3) . This finding provides direct evidence for fusion of B cells and MHV-infected cells. DISCUSSION 'B cell-mediated lysis' of MHV-infected target cells has been reported at the population level by Holmes et al. (1986) and Welsh et al. (1986) . In the present study we have shown that lysis of MHV-infected target cells is not actually mediated by unprimed B cells, but results from fusion between B cells and MHV-infected target cells. We have found that this fusion-mediated lysis differs from classical T cell-mediated cytolysis of virus-infected cells in three important ways. First, cytolysis occurs in an MHC-independent manner Zinkernagel & Doherty, 1970) . Secondly, cytolysis is independent of immune receptor specificity, and in fact even occurs in the absence of B cell immune receptors (immunoglobulin). Thirdly, cytolysis is associated with fusion of effector and target cells. An additional difference not demonstrated in this paper is that cytolysis occurs in the absence of divalent cations .
The MHV E2 glycoprotein attaches virus to specific cellular receptors (Holmes eta/., 1981) , and mediates the subsequent fusion of viral and cellular membranes (Collins eta/., 1982 fusion activity is dependent on host cell-mediated cleavage of E2 into non-covalently linked subunits . The degree of E2 cleavage varies between host cells (Frana et al., 1985) . The previous finding that monospecific anti-E2 serum inhibits B cell lysis , taken together with our demonstration that cytolysis is associated with effector-target cell fusion, provides strong evidence that E2 plays a central role in the lysis of MHV-infected target cells. In additional experiments, we have found that Sp2/0 cells can be infected by MHV, and therefore presumably express MHV receptors. Based on this finding, it is tempting to speculate that the failure to observe cytotoxicity in the presence of other immune cells is related to the absence of MHV receptors. Although the expression of MHV receptors has been reported to vary between mouse strains [in parallel with susceptibility to MHV-A59 infection (Boyle et al., 1987) ], variation in receptor expression between cell types has not been reported. Furthermore, other factors must play a role in cytolysis, since uninfected 17Cll and L929 cells do not lyse MHV-infected 17Cll cells (unpublished results). Additional factors may include the production of enzymes by B cells capable of cleaving uncleaved E2 on the target cell surface, and features of the B cell membrane that enhance fusion with MHV-infected target cells. Fusion-mediated cytolysis has been demonstrated and suggested as a contributing factor to the loss of CD4 + T cells in human immunodeficiency virus infection (Lifson et al., 1986; Sodroski et al., 1986) . Its role, however, in non-MHC-restricted cytolysis observed with mumps, Sendai and herpes simplex virus infections has not been defined (Alsheikly et al., 1983; Andersson et al., 1975 ; Fitzgerald et al., 1982 Fitzgerald et al., , 1983 H~rfast et al., 1975) . Cell-mediated lysis in each instance was virus-dependent and clearly different from natural killer cell-mediated lysis. It was proposed (Fitzgerald et al., 1983 ) that different classes of natural killer cells were present, but the possibility of cytolysis analogous to that observed in the MHV system has not been examined. The fact that each of these viruses, like MHV, fuses with cells at neutral pH and induces syncytium formation in vitro supports this possibility. Findings in these other virus systems should be re-examined to determine whether fusion of B cells or other immune cells with virus-infected target cells occurs and accounts for cytolysis and virus-associated inactivation of specific elements of the immune system. This work was supported by grants AI 14162 and CA-38951 from the National Institutes of Health, Bethesda, Md., U.S.A.
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